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Tissue renewal is a well-known phenomenon by which old and dying-off cells of various
tissues of the body are replaced by progeny of local or circulating stem cells (SCs). An
interesting question is whether donor SCs are capable to prolong the lifespan of an aging
organism by tissue renewal. In this work, we investigated the possible use of bone
marrow (BM) SC for lifespan extension. To this purpose, chimeric C57BL/6 mice were
created by transplanting BM from young 1.5-month-old donors to 21.5-month-old recipients.
Transplantation was carried out by means of a recently developed method which allowed
to transplant without myeloablation up to 1.5 × 108 cells, that is, about 25% of the total
BM cells of the mouse. As a result, the mean survival time, counting from the age of
21.5 months, the start of the experiment, was +3.6 and +5.0 (±0.1) months for the
control and experimental groups, respectively, corresponding to a 39 ± 4% increase in the
experimental group over the control. In earlier studies onBM transplantation, a considerably
smaller quantity of donor cells (5 × 106) was used, about 1% of the total own BM cells.
The recipients before transplantation were exposed to a lethal (for control animals) X-ray
dose which eliminated the possibility of studying the lifespan extension by this method.
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INTRODUCTION
It is presently held that many tissues of an adult organism are
capable of regeneration (self-renewal) by means of resident or
circulating stem cells (SCs). The self-renewal of tissues occurs
continuously. In the heart of rats, for example, about 7% of
the cells are replaced every month (Kajstura et al., 1996), whereas
the renewal of blood and epithelial tissues proceeds much faster.
The participation of not only local but also circulating SC in
the renewal of tissues has been shown by numerous studies on
sex-mismatched transplantation which was accompanied by sig-
niﬁcant y/x-chimerism (Körbling et al., 2002; Herzog et al., 2003;
Thiele et al., 2004). The signiﬁcance of these studies is especially
increased now since it has become possible to create cellular mate-
rial for transplantation that is genetically identical to cells of the
patient (Grewal et al., 2004; Takahashi and Yamanaka, 2006; Wang
et al., 2011).
Our previous in vitro studies have demonstrated that non-
differentiated SC can indeed, under certain conditions, be effec-
tively differentiated into the cell type corresponding to their
cellular microenvironment (Kovina and Khodarovich, 2011).
These ﬁndings may explain the previously found, and not enough
accounted for, effectiveness of bone marrow transplantation
(BMT) in treating not only hematology diseases (Fanconi ane-
mia; Gluckman et al., 1995) but also such systemic diseases as
mucopolysaccharidosis and senile hearing impairment (Birken-
meier et al., 1991; Iwai et al., 2001; Corti et al., 2004; Willenbring
et al., 2004). Mucopolysaccharidosis is caused by a deﬁciency
in enzymes required for degradation of glucosamines that are
accumulated in lysosomes of many organs, thereby leading to dys-
function and reduction of lifespan. Transplantation of syngenic
bone marrow (BM) cells from healthy mice resulted in an increase
of lifespan from 6 months to the control value of 2 years. The
lysosomal activity was recovered in full or in part in all studied
tissues. For the thymus gland, spleen, and BM the recovery was
complete, for the lungs it was 50%, for kidney and liver, 20%,
and for the brain, 7% (Birkenmeier et al., 1991). This result can
be logically accounted for by tissue replacement with progeny of
donor BM; however, the authors did not determine the degree of
chimerism. In the next work of this series, the curing of a hered-
itary skin disease by BMT was shown; the chimerism of skin was
determined to be between 10 and 30%, and the chimerism of the
mucous epithelium of the gastrointestinal tract was 50% (Wagner
et al., 2010). These facts led to the assumption that the BM, besides
hematopoietic and stromal cells, contains cells capable to be dif-
ferentiated into mature cells of many other tissues (Herzog et al.,
2003).
Nevertheless, it is still unclear whether such regeneration can
retard the normal process of aging. The BMT methods employed
before demanded a strong X-ray irradiation which negatively
affected the lifespan of control animals (Birkenmeier et al., 1991).
Though there are some life extension reports about myeloablat-
ing SC transplantation on mice (Shen et al., 2011), the usage of
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lethal irradiation cannot be recommended for human anti-aging
therapy. In the present work, we report the inﬂuence upon lifespan
of high yield non-myeloablating transplantation of BM from
young mice to old mice.
MATERIALS AND METHODS
ISOLATION OF BONE MARROW
All animal experiments were conducted in accordance with
the Guiding Principles in the Use of Animals in Toxicology
(http://www.toxicology.org/ai/air/air6.asp) and were approved by
Institutional Animal Care and Use Committee (IACUC). The
donors of BM were C57BL/6 mice aged 6 weeks. The donors were
sacriﬁced by cervical dislocation and sanitized with 70% ethanol.
Isolation of BM was carried out as described (Colvin et al., 2004)
with small variations. Firstly, the spine and skull were cut out
and freed of surrounding tissues using sterile scalpel, scissors, and
forceps. The caudal part of the spine was removed. The spine
and skull bones were then minced with sterile pistil and mortar
in 1–2 ml of cooled sterile Hanks’ balanced salt solution (HBSS)
buffer of the following composition: 0.44 mM potassium phos-
phate, 5.37 mM potassium chloride, 0.34 mM dibasic sodium
phosphate, 136.89 mM sodium chloride, 5.55 mM D-glucose. The
mixture was ﬁltrated through four layers of a ﬁne-mesh nylon-6
tissue, washed in fresh HBSS buffer and then centrifuged under
mild conditions (50 g). The deposit was resuspended in 1 ml
HBSS, the cells were counted in a Goryaev chamber and HBSS
was added to a ﬁnal concentration of 5 × 107 cells per ml. The
overall number of isolated cells of various sizes and morphology
was 3.5–4.5 × 108.
TRANSPLANTATION OF BONE MARROW
Bone marrow was transplanted to C57BL/6 mice aged 21.5
months. Pre-treatment of suspension of the cells included ﬁltra-
tion through four layers of a ﬁne-mesh nylon-6 tissue and addition
of 5 U of heparin (Synthesis, Russia) per 2.5 × 107 cells in 0.5 ml
HBSS to prevent occlusions of vessels with cellular material. The
tail of a mouse was warmed in water at 50–55◦C until the twin
caudal veins were clearly seen, and then the cell suspension was
slowly (during 20 s) injected into one of the veins by means of an
insulin syringe.
Transplantations were carried out twice a day on three subse-
quent days with an interval of 8–16 h, which brought the amount
of transplanted cells up to 1.5 × 108 per recipient.
The control animals did not receive any treatment.
STATISTICAL TREATMENT OF DATA
Approximation of experimental results was done using the Origin
software (OriginLab, USA) on the basis of the Gompertz function,
traditionally used for survival description (Anisimov et al., 2003;
Gavrilov and Gavrilova, 2006):
F(t) = 100 × exp[−P1 × exp(P2 × t − P3)], (1)
where F(t) is the percentage of animals that attained age t, 100%
is the number of animals at the age 21.5 month (the age-point
when the transplantation was performed), and P1, P2, and P3 are
parameters to adjust. To ﬁnd the best ﬁt, we conducted a three-
parametric ﬁt for each experimental curve and obtained three
pairs of parameters. Then the least sensitive parameter (P1) was
averaged andﬁxed for a two-parametric ﬁt (P2 andP3). Then again
the least sensitive (P3)was averaged and ﬁxed for a one-parametric
ﬁt (P2).
To ﬁnd the 50%-survival time (t1/2) for each curve, we used
the following equation, derived from Eq. 1:
50 = 100 × exp[−P1 × exp(P2 × t1/2 − P3)],
t1/2 = [P3 + In((In(2))/P1)]/P2 (2)
RESULTS AND DISCUSSION
In the beginning, we selected conditions for massive transplanta-
tion of BM cells to mice. According to the idea of the experiment,
we needed to inject about 150 million cells (1.5 × 108) to each
animal, which amounts to nearly one-fourth of overall BM cells
of an adult mouse. It turned out that after injection of a large
volume (over 1 ml) or of a highly concentrated cell suspension
(1–1.5 × 108/ml) most mice died within 2–10 min. Therefore, the
following conditions of transplantationwere chosen: the cells were
injected in six portions of 2.5 × 107 cells in 0.5 ml at intervals of
8–16 h. An important factor for successful transplantation was the
addition of 5 U of heparin per cell dose (2.5 × 107 cells in 0.5 ml)
and a thorough ﬁltration of the cells before injection; combining
these two measures greatly reduced post-transplantation death of
the animals.
The recipients of BM cells were C57BL/6 mice at the age of 21.5
months. Each of the 10 females received 1.5 × 108 cells obtained
from 6-week-old males of the same line. In each case the quantity
of live BM cells exceeded 90%, which was ascertained by count-
ing cells stained with trypan blue in a Goryaev chamber. Two
recipients were lost during transplantations, presumably from for-
mation of thrombi in large vessels; they were excluded from the
statistical analysis. The remaining eight mice were observed until
their natural death in parallel to nine mice of the same age from
a control group not exposed to transplantation. Figure 1 depicts
the effect of BM transplantation on lifespan. The gray line corre-
sponding to the group of recipients is always above the black line
of the control group.
Statistical analysis of the results was performed as described
in Section “Materials and Methods.” The Gompertz equation
describes the experimental data sufﬁciently good, with the cor-
relation coefﬁcient 0.9. The best ﬁt gave the following values of
the mean total lifespan:
t1/2cntrl = 25.1 ± 0.1 months and t1/2trnspl = 26.5 ± 0.1 months.
Then, the mean residual lifespan, calculated from the beginning of
the observations (age = 21.5 months), was 25.1–21.5 = 3.6 ± 0.1
months and 26.5–21.5 = 5.0 ± 0.1 months for the control and
experimental groups, respectively, corresponding to a gain of 5.0–
3.6= 1.4months (Figure 1). Hence, the BMTcarried out using the
described procedure resulted in a (1.4/3.6) × 100% = 39 ± 4%
increase of the mean survival time counting from the moment
of transplantation. While the overall lifespan extension is mod-
est (100 × 1.4/25.1 = 6%) we discuss here only the post-
transplantation extension (39%), since it properly reﬂects the
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FIGURE 1 | Effect of massive non-myeloablating syngenic
transplantation of bone marrow on the lifespan of C57BL/6 mice. Black
line – Kaplan–Meier graph for animals from the control group (solid line) and
its Gompertz approximation (dashed line); gray line – Kaplan–Meier graph
for animals from the experimental group which underwent bone marrow
transplantation (solid line) and its Gompertz approximation (dashed line).
BMT, bone marrow transplantation.
effect of the treatmentwhile the overall ratio includes theuntreated
time. This is a common practice (Dhahbi et al., 2004). The
untreated time is several fold greater than post-treatment time
and, therefore, cannot be ignored as might be done when the
treatment starts soon after weaning. There is no known method to
extend the mean wt-mouse life for more than 40% after the start
of the treatment, even with dietary restriction, the most powerful
method of life extension.
The oldest transplanted animal lived 3 weeks longer than the
oldest control animal., However we cannot calculate the max-
imal lifespan here, since it is, by deﬁnition, the mean lifespan
of the most long-lived 10% of each group. In our small group,
10% would be less than one mouse. So, the investigation of
an inﬂuence of BMT on maximal lifespan is the task for future
work.
The obtained positive inﬂuence of BMT on the mean lifespan
in our work is underestimated because of transplantation compli-
cations (including the occlusion of vessels) from which, obviously,
suffered not only the two mice that died during transplantation
and were excluded from the statistics, but also those that sur-
vived, though to a lesser degree. We expect a greater difference in
lifespan between control and experimental groups by (i) the use
of high-quality commercial ﬁlters for puriﬁcation of transplanted
material from cell aggregates and (ii) the use of more accurate con-
trols injected with old BM (in this work the control animals did
not get the parallel invasive treatment because of the absence of
additional 20 months old animals to produce old BM for control
transplantation).
Data from the literature also suggest an effect of BMT on the
lifespan of mice. For instance, an attempt was made in 2004 to
extend the lifespan with syngenic radiation-free transplantation
of 4–10 × 106 BM cells from young donors (Kamminga et al.,
2005). The effect was not large though (less than 10% of the
survival increase), presumably because a relatively small num-
ber of cells were transplanted; the resulting chimerism of the
BM was also quite modest (1–10%). However, very soon another
research team managed to achieve 30–37% chimerism of young
recipients after transplantation of 2 × 108 BM cells without irra-
diation (Colvin et al., 2004), which is in a perfect agreement with
the SC competition hypothesis (an adult mouse has a total of
6 × 108 BM cells). The SC competition hypothesis predicts a still
greater effectiveness of replacement of the aging recipient’s BM
with young donor’s SCs, as the amount of SCs decreases sharply
with age.
In perfect agreement with this prediction, the chimerism of old
recipients in the above-mentioned study (Kamminga et al., 2005)
was 10- to 20-fold greater than chimerism found in younger recip-
ients (5–10 vs. 0.5–1%). Therefore, when the amount of donor
cells is increased 10–20 times (from 5–10 × 106 to 1–2 × 108)
one may expect an almost complete replacement of the aged BM
with that from the donor. Thus, our results which demonstrate
a signiﬁcant effect of BMT on mice survival may be explained as
solely by a blood renewal effect (for example, immune boosting
effect or increased blood oxygenic capacity), as well as by large
number of transplanted cells incorporated in the solid organs and
differentiated into the surrounding tissue, thus renewing it. The
last conclusion is supported by the results of our previous work
on contact differentiation in vitro, where we achieved nearly 100%
differentiation of SCs into endotheliocytes after seeding them into
a primary endothelial culture (Kovina and Khodarovich, 2011).
In our work, we used a slightly different source of BM as
it is obtained traditionally – spine and scull instead of femurs.
Spine and scull together contain the majority (63%) of total body
BM cells, according to Colvin et al. (2004). Besides, BM from
spine and scull has a twice higher percentage of high prolifer-
ative potential colony-forming cells, than femurs (Colvin et al.,
2004). So, it must have a higher potential to renew old tissues than
femur’s BM. Finely, spine and scull are easily cleaned from sur-
rounded tissues. Thus, in order to recover the maximal amount
of active BM within minimal time, we decided to use only spine
and scull as BM sources. A quantitative assessment of the degree
of post-transplantation chimerism and its correlations with lifes-
pan on a larger quantity of animals with variations in both: the
sources of circulating SC and the lines of recipients will be the
next stage of our work. A success along these lines will allow
developing approaches for therapy for not only a number of
hereditary diseases but also for retardation of the aging process in
general.
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